TTRX Turn Therapeutics, Inc.

NASDAQ
$8.55

Turn Therapeutics, Inc. (TTRX) is expected to report earnings on February 8, 2027, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of -7.8% since its last earnings release on November 9, 2026.

Turn Therapeutics Reported Earnings
Monday, November 9, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 8
Monday · 4:30 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $9.40

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Turn Therapeutics, Inc.

Turn Therapeutics is a clinical-stage biotechnology company developing next-generation dermatology, wound and anti-infective therapies. Turn Therapeutics is based in WESTLAKE VILLAGE, Calif.

Charts powered in part by Lightweight Charts™ by TradingView.